We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Biotech Growth Trust plc (The) (BIOG) Ordinary 25p

Sell:970.00p Buy:976.00p 0 Change: 6.00p (0.62%)
Market closed Prices as at close on 19 August 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 6.00p (0.62%)
Market closed Prices as at close on 19 August 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 6.00p (0.62%)
Market closed Prices as at close on 19 August 2022 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Trade high:
Year high:
Estimated NAV:
Previous close:
Trade low:
Year low:
9.00p (0.93%)
Dividend yield:
Data delayed by at least 15 minutes.


  • Net Asset Value (NAV)
BIOTECH GWTH performance chart


BIOTECH GWTH performance chart
Full interactive share price and premium / discount charts


1 week 1W 0.61% 1 year 1Y 16.52%
1 month 1M 11.05% 2 years 2Y 20.21%
3 months 3M 18.9% 3 years 3Y 24.05%
6 months 6M 3.61% 5 years 5Y 23.81%

Performance figures are based on the previous close price. Past performance is not an indication of future performance.

Trust Basics

Benchmark: NASDAQ Biotechnology TR GBP
Annual management charge: n/a
Performance fee: No
Ongoing charge: 1.10%
Dividend yield: n/a
Dividend frequency: None
Total assets: £482m
Gross gearing: 111%
Market capitalisation:Market cap.: £393m
Shares in issue: 40.71 million
Legal structure Closed Ended Investment Company
Domicile: United Kingdom
ISIN GB0000385517

Dividend information for this stock is not available.

Dividend information for this stock is not available.

Ready to invest?

To buy shares in , you'll need to have an account.
Try our handy filter to explore the different options.

Compare accounts

Ready to invest?

To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.

Compare accounts

Important Documents


The Company seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.


Estimated NAV: 1,064.02
Latest actual NAV: 921.36
Latest actual NAV date: 22 February 2022
Premium/Discount: -9.21%
12m average Premium/Discount: -3.96%
NAV frequency: Daily

Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.

Security Weight
Biomarin Pharmaceutical Inc 5.54%
Seagen Inc Ordinary Shares 4.89%
Horizon Therapeutics plc Ordinary Shares 4.78%
Keros Therapeutics Inc 4.73%
Syndax Pharmaceuticals Inc 4.21%
GH Research PLC 4.11%
Yisheng B - Pfd 4.09%
Xenon Pharmaceuticals Inc 3.87%
Gilead Sciences Inc 3.70%
Vaxcyte Inc Ordinary Shares 3.52%
Sector Weight
Healthcare 100.32%
Country Weight
United States 79.56%
Canada 7.29%
China 5.46%
Ireland 4.11%
United Kingdom 2.48%
France 0.53%
Germany 0.34%
Switzerland 0.29%
Singapore 0.23%
Denmark 0.10%

Key Dates

Launch date: 23 June 1997
Financial year end: March
Next AGM: July 2023
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset. Dividend data provided by Digital Look. Recent trade data provided by MoneyAM. Trust basics, holding data, key dates, objective and NAV provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.